Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in

Cough, Cold and Allergy (Hay Fever) Remedies in Uzbekistan

18 pages, Nov 2017

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PROSPECTS

The number of people suffering from allergies has risen

According to the Chief Allergist of the Ministry of Health of the Republic of Uzbekistan, even 15 years ago only 5-10% of the population suffered from allergies. Today, due to impact of many various factors this number has increased by several times.

Cough remedies are mostly used in winter, with children presenting the most frequent need for these treatments

If demand for allergy remedies increases in the late spring, cough remedies are mainly consumed during winter. Winter is cold in Uzbekistan, and thus, the majority of people – especially children – catch a cold in that season.

New launches will likely boost cough, cold and allergy remedies category

Due to new regulations, many changes are expected in the pharmaceutical industry. Some brands will likely disappear due to discommodity, whereas new brands will be presented to consumers.

COMPETITIVE LANDSCAPE

Multinationals dominate sales, with Nycomed on top

Nycomed Pharma held the leading position in cough, cold and allergy (hay fever) remedies in 2017. The company benefited from long presence in the Uzbekistani consumer health market and from popularity of its Nasivin brand in both spray and drops.

Bristol-Myers’ Fervex performs better than GSK’s Coldrex largely due to its lower cost

After its acquisition of Novartis’ consumer health portfolio, GSK Consumer Healthcare strengthened its position in cough, cold and allergy remedies. GSK’s Coldrex, Tavegil and Dlyanos pulled the company into third place in Uzbekistan.

Uzbekistani producers remain weak

Unlike other OTC categories, where Uzbekistani producers have increased their value shares by squeezing out foreign companies, the situation in cough, cold and allergy remedies was very different in 2017. Uzbekistani pharmaceutical companies are very weak in the category; consequently, they cover an insignificant part of it.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Cough, Cold and Allergy Sample Report Cough, Cold and Allergy Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Uzbekistan with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Uzbekistan, our research will save you time and money while empowering you to make informed, profitable decisions.

The Cough, Cold and Allergy (Hay Fever) Remedies in Uzbekistan market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Cough, Cold and Allergy (Hay Fever) Remedies in Uzbekistan?
What are the major brands in Uzbekistan?
What is the impact of influenza vaccinations on the sales of cough and cold products?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Cough, Cold and Allergy (Hay Fever) Remedies in Uzbekistan - Category analysis

HEADLINES

PROSPECTS

The number of people suffering from allergies has risen

Cough remedies are mostly used in winter, with children presenting the most frequent need for these treatments

New launches will likely boost cough, cold and allergy remedies category

COMPETITIVE LANDSCAPE

Multinationals dominate sales, with Nycomed on top

Bristol-Myers’ Fervex performs better than GSK’s Coldrex largely due to its lower cost

Uzbekistani producers remain weak

CATEGORY DATA

Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2012-2017
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2012-2017
Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2013-2017
Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2017
Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2017-2022
Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2017-2022

Consumer Health in Uzbekistan - Industry Overview

EXECUTIVE SUMMARY

Prospects are promising for the Uzbekistani consumer health market

New regulations influence the market significantly in 2017

The number of domestic producers is growing

Consumer health products are sold only in pharmacies

Volume sales slow down in 2017 but promise to grow in the nearest future

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
Table 8 Life Expectancy at Birth 2012-2017

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2012-2017
Table 10 Sales of Consumer Health by Category: % Value Growth 2012-2017
Table 11 NBO Company Shares of Consumer Health: % Value 2013-2017
Table 12 LBN Brand Shares of Consumer Health: % Value 2014-2017
Table 13 Distribution of Consumer Health by Format: % Value 2012-2017
Table 14 Distribution of Consumer Health by Format and Category: % Value 2017
Table 15 Forecast Sales of Consumer Health by Category: Value 2017-2022
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022

Megatrends

Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in Uzbekistan

New Report Guarantee

Executive Summary

New Report Guarantee

PROSPECTS

The number of people suffering from allergies has risen

Cough remedies are mostly used in winter, with children presenting the most frequent need for these treatments

New launches will likely boost cough, cold and allergy remedies category

COMPETITIVE LANDSCAPE

Multinationals dominate sales, with Nycomed on top

Bristol-Myers’ Fervex performs better than GSK’s Coldrex largely due to its lower cost

Uzbekistani producers remain weak

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

Cough, Cold and Allergy (Hay Fever) Remedies in Uzbekistan - Category analysis

HEADLINES

PROSPECTS

The number of people suffering from allergies has risen

Cough remedies are mostly used in winter, with children presenting the most frequent need for these treatments

New launches will likely boost cough, cold and allergy remedies category

COMPETITIVE LANDSCAPE

Multinationals dominate sales, with Nycomed on top

Bristol-Myers’ Fervex performs better than GSK’s Coldrex largely due to its lower cost

Uzbekistani producers remain weak

CATEGORY DATA

Consumer Health in Uzbekistan - Industry Overview

EXECUTIVE SUMMARY

Prospects are promising for the Uzbekistani consumer health market

New regulations influence the market significantly in 2017

The number of domestic producers is growing

Consumer health products are sold only in pharmacies

Volume sales slow down in 2017 but promise to grow in the nearest future

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports